iQure Pharma

Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. The company focuses on enhancing astrocytic regulation of glutamate up...

Healthcare

Princeton, NJ, United States

Founded 2019

7 employees

Website

Valuation

$21M

Market implied

Share Price

N/A

Total Raised

$13.1M

Last Round

N/A

Investors

+8 other investors

View all 8 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock iQure Pharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required